INSTITUTO ROSENBUSCH S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.9 ARS | -2.84% |
|
-2.95% | +38.91% |
| Sales 2022 | 1.37B 1.56M 125M | Sales 2023 | 4.53B 5.16M 411M | Capitalization | 2.73B 3.1M 247M |
|---|---|---|---|---|---|
| Net income 2022 | -8M -9.11K -726K | Net income 2023 | 563M 641K 51.09M | EV / Sales 2022 | 0.57 x |
| Net Debt 2022 | 238M 271K 21.63M | Net Debt 2023 | 643M 732K 58.36M | EV / Sales 2023 | 0.74 x |
| P/E ratio 2022 |
-67.8
x | P/E ratio 2023 |
4.84
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.67% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.84% | ||
| 1 week | -2.95% | ||
| Current month | -23.69% | ||
| 1 month | -23.69% | ||
| 3 months | -14.52% | ||
| 6 months | +85.98% | ||
| Current year | +38.91% |
1 week
86.00
91.50
1 month
86.00123.00
Current year
60.00135.00
1 year
14.00135.00
3 years
9.00135.00
5 years
4.20135.00
10 years
2.55135.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Oscar Echeverria
DFI | Director of Finance/CFO | - | - |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Corporate Officer/Principal | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/05/24 | 86.5 | -.--% | 1,300 |
| 30/04/24 | 86.5 | -2.70% | 284 |
| 29/04/24 | 88.9 | -2.84% | 2,231 |
| 26/04/24 | 91.5 | -.--% | 250 |
| 24/04/24 | 91.5 | -.--% | 200 |
End-of-day quote Buenos Aires S.E., April 28, 2024
More quotes
Instituto Rosenbusch SA de Biologia Experimental Agropecuaria is an Argentina-based company primarily engaged in the production and sale of such veterinary products as antiparasitic drugs, vitamins, hormone treatments and vaccines, among others. The Company's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. It is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +38.91% | 4.21M | |
| -9.60% | 6.48B | |
| +24.75% | 3.7B | |
| -3.20% | 3.1B | |
| +2.53% | 1.44B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -6.64% | 1.19B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B |
- Stock Market
- Equities
- ROSE Stock
